August 19, 2014 – 10:01 am
Some people have recently suggested that all women have biopsies of their fibroids before surgery to determine which women have typical fibroids and which women might have a leiomyosarcoma (LMS). There are many problems with this idea. To start, I am going to use the word tumor throughout this post. When we hear” tumor”, most […]
A recent article in the Journal of the American Medical Association (JAMA) reported that the rate of uterine cancer among women having surgical procedures using morcellation was 1 woman out of 368. Since the recent FDA hearing was about morcellation and the risk of finding uterine leiomyosarcoma (LMS), some of the media have misinterpreted this […]
There is a lot of confusing information circulating about morcellation and uterine leiomyosarcoma in the media since the FDA hearing on this issue a few weeks ago. I plan to post my analysis of the information, in segments, over the next week or two. This first post provides commentary about the numbers used in research […]
By webmaster
|
Posted in Recent Fibroid Research
|
Tagged FDA, fibroids, laparoscopic myomectomy, laparoscopy, LMS, Morcellation, morcellation risks, myomectomy, power morcellation, risk of LMS, risk of Uterine Leiomyosarcoma, robotic myomectomy, uterine leiomyosarcoma
|